InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: flipper44 post# 188548

Thursday, 09/06/2018 6:40:59 PM

Thursday, September 06, 2018 6:40:59 PM

Post# of 700723
Flipper44,

you will not believe me but 2 hours ago I was looking for that same GMP report that I had found a few weeks earlier on the web but I had totally forgotten where I had found it. And just now there is your post. Indeed very funny and thank you! It saved me a lot of time.

This is of the GMP report 2017:

Cell and Gene Therapy GMP Manufacturing in the UK: Capability and Capacity Analysis October 2017

https://ct.catapult.org.uk/sites/default/files/publication/GMP%20Manufacturing%20Report%202017%2030_12_17%20FINAL.pdf

5 Future Capacity and Expansion

Phase 1 of Advent Bioservices’ own new facility in Cambridgeshire, is due to be licensed and operational from Q1 2018 and includes two completed suites (185m2 each), comprising B, C and PD/QC labs, offices and storage space. This facility is due to bring to market 199 m2 of cleanroom footprint (including MAL & PAL areas) in its first phase. However, the site has capacity for a further ~7,500 m2 of additional development.
(Under development) Vision Centre A1301 Sawston Bypass Cambridgeshire CB22 3JG
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News